Westwood-Squibb Colton Holdings Partnership

Westwood-Squibb Colton Holdings Partnership was a specialized legal entity and intellectual property holding structure associated with the dermatology division of Bristol Myers Squibb. The partnership was established following the acquisition of Westwood Pharmaceuticals by Bristol-Myers in 1989, involving the Colton family who were the original owners of Westwood. It primarily managed the patent rights and royalty streams for a portfolio of dermatological products, including the widely used psoriasis treatment Dovonex. The entity served as a vehicle for managing the financial and legal interests of the legacy Westwood assets during their integration into the larger Bristol Myers Squibb organization. As Bristol Myers Squibb transitioned its focus toward specialty biopharmaceuticals like oncology and immunology, the dermatology assets were largely divested to LEO Pharma and other entities.